12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

• IsoPlexis ISO shares moved upwards by 43.5% to $0.99 during Wednesday's after-market session. The market value of their outstanding shares is at $39.1 million.
• Phio Pharma PHIO stock rose 40.39% to $0.53. At the close, Phio Pharma's trading volume reached 934.6K shares. This is 1433.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.1 million.
• Eledon Pharma ELDN shares increased by 17.02% to $2.88. The company's market cap stands at $39.6 million.
• Virpax Pharmaceuticals VRPX shares increased by 16.43% to $0.85. The company's market cap stands at $9.9 million.
• Accelerate Diagnostics AXDX stock increased by 14.57% to $0.73. The company's market cap stands at $72.3 million.
• BIMI Intl Medical BIMI stock moved upwards by 8.07% to $1.74. The company's market cap stands at $6.6 million.

Losers

• Exicure XCUR shares decreased by 9.9% to $1.0 during Wednesday's after-market session. Exicure's trading volume hit 99.3K shares by close, accounting for 90.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.9 million.
• Fortress Biotech FBIO shares declined by 7.0% to $0.53. The company's market cap stands at $57.5 million.
• Berkeley Lights BLI stock fell 6.28% to $2.24. The market value of their outstanding shares is at $153.6 million.
• Surrozen SRZN shares decreased by 5.85% to $0.46. Today's trading volume for this security ended up closing at 325.3K shares, which is 83.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $16.1 million.
• Enveric Biosciences ENVB stock fell 5.76% to $1.8. The market value of their outstanding shares is at $3.7 million.
• Applied Molecular AMTI stock decreased by 5.67% to $1.0. The company's market cap stands at $38.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.